Ophthalmic Business News

Doctors have active minds and creativity to solve problems from the perspective of someone who takes care of patients all day.

Patients with dry eye disease experienced improvements in ocular discomfort after treatment with reproxalap, according to a press release from Aldeyra Therapeutics.

Ocular Therapeutix obtained FDA support to use the phase 3 SOL-R trial as the next step in the regulatory process for Axpaxli, according to a press release.

The Federal Trade Commission proposal to ban noncompete clauses for all workers has sent powerful ripples through the health care industry, prompting physicians of all specialties to reevaluate their career trajectories.

The European Commission approved Vabysmo for the treatment of visual impairment due to macular edema secondary to retinal vein occlusion, according to a press release from Roche.

In this episode, John A. Hovanesian, MD, FACS, and Jim Mazzo chat with Cathleen McCabe, MD, about the ASCRS Foundation and role models in ophthalmology; plus, the latest news in eye care.

On April 23, the Federal Trade Commission released a final rule banning most noncompetition clauses in employer-employee contracts as unfair methods of competition.

The ViaLase laser received a CE mark for the treatment of adults with primary open-angle glaucoma, according to a press release.

The FDA granted 510(k) clearance to the Faros anterior cataract surgery system from Oertli Instrumente, according to a press release.

Anyone who has read any of my drivel knows that I am a long-time fan of testing tear osmolarity to guide the diagnosis and treatment of dry eye disease.